RESOURCES & PERSPECTIVES

  1. Increasing The Usefulness Of PROs In Oncology Research 2/20/2024

    Dr. Anthony Everhart (Clinical VP, Signant Health) and Tim Meyer (Professor, University College London) discuss opportunities for increasing the usefulness of PROMs.

  2. 7 eCOA Design Recommendations: Insights From Sites And CRAs 2/20/2024

    Signant joined a group of C-Path members including other eCOA solution providers, sponsors, and regulators for a GBTI project that revealed several opportunities to improve eCOA usability and flexibility.

  3. Still Using Paper Diaries To Capture PRO Data? Read This. 1/8/2024

    Access real-world examples of how electronic patient-reported outcome measures (PROMs) optimize data quality and reliability and improve the statistical power of trial data.

  4. Optimal COA Measurement Strategy In Modern Oncology Trials: Insights 8/29/2023

    Explore the challenges and opportunities in implementing patient-reported outcome measures (PROMs) in oncology trials. This article discusses the recent FDA draft guidance, emphasizing how more targeted PROM strategies could lead to better medication labeling and patient care in cancer treatment.

  5. EMA Paper Overview: Decentralized Elements In Clinical Trials 8/29/2023

    Review a summary of themes highlighted from the recent EMA recommendation paper concerning decentralized components within regulatory submissions for clinical trials.

  6. What 4 Things Do All eCOA Studies Need To Succeed? 8/8/2023

    Learn what else, in addition to good technology, study teams need for eCOA studies to succeed.

  7. 3 Themes And Takeaways From FDA's Draft Guidance On DCTs 8/8/2023

    Get our experts’ summary of recent regulatory guidance as well as recommendations for optimal decentralized clinical trial design and conduct.

  8. Computerized Adaptive Tests Using PROMIS CAT 8/8/2023

    Learn how Signant’s unique PROMIS CAT captures high-quality COA data while reducing completion burden.

  9. Increase Participant Diversity With eClinical Tools 4/14/2023

    The right technology and community partnerships can help sponsors meet FDA diversity requirements without additional expenditures, build relationships with minorities, and prepare for future trials.

  10. Finally, A Unified eClinical Platform With One Login 4/10/2023

    Make hybrid and decentralized clinical trials expedient and cost-effective, without time-consuming integrations, lengthy start-up times, or specialized staff with unified eClinical solutions.